Prevention of diabetes in South Asians with impaired glucose levels: a family based clinical trial using physical activity and dietary modification

ISRCTN ISRCTN25729565
DOI https://doi.org/10.1186/ISRCTN25729565
Secondary identifying numbers G0501310
Submission date
29/01/2007
Registration date
30/01/2007
Last edited
18/03/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

http://www.podosa.org/faq.html

Study website

Contact information

Prof Raj Bhopal
Scientific

Public Health Sciences
University of Edinburgh
Teviot Place
Edinburgh
EH8 9AG
United Kingdom

Phone +44 (0)131 650 3216
Email Raj.bhopal@ed.ac.uk

Study information

Study designControlled cluster randomised trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typePrevention
Participant information sheet Patient information can be found in http://www.podosa.org/faq.html
Scientific title
Study acronymPODOSA
Study hypothesisCurrent information as of 26/04/10:
Does a family-based three-year programme promoting weight loss and increased physical activity in South Asians with impaired glucose tolerance and/or impaired fasting glucose, result in a clinically meaningful weight loss in the intervention group compared to the control group?

Initial information at time of registration:
To evaluate whether a 3-year family based programme combining weight loss and physical activity can reduce the incidence of type 2 diabetes in South Asians with impaired glucose tolerance.

Please note that as of 26/04/10, this record has been updated. All updates may be found in the relevant field with the above update date. Please also note that the anticipated end date of this trial has been extended from 31/07/11 to 31/01/13.
Ethics approval(s)Added 27/04/10:
Scotland A Research Ethics Committee approved on the 15th of March 2007 (ref: 07/MRE10/2). Substantial amendment to protocol to change primary outcome and sample size was approved on the 29th of June 2009
ConditionNutritional, Metabolic and Endocrine Diseases: type 2 Diabetes
InterventionIntervention group will receive 15 contacts with trained dieticians over 3 years with the goal of reducing weight and increasing physical activity.
Control group will receive 4 contacts over 3 years to provide health information.

Current information as of 26/04/10:
Intervention and control group - 85 recruits in each group plus family volunteers.

Initial information at time of registration:
Intervention and control group - 300 recruits in each group plus family volunteers.
Intervention typeOther
Primary outcome measureCurrent information as of 26/04/10:
Weight change at 3 years.

Initial information at time of registration:
To evaluate whether a 3-year family based programme combining weight loss and physical activity can reduce the incidence of type 2 diabetes in South Asians with impaired glucose tolerance.
Secondary outcome measuresAdded 26/04/10:
1. Changes in fasting and 2-hour glucose
2. Progression to type 2 diabetes
3. Body Mass Index (BMI)
4. Waist circumference and hip circumference
5. Cost effectiveness
Overall study start date01/08/2006
Overall study end date31/07/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participantsUpdated 26/04/10: 170 (At time of registration: 600 recruits with IGT [approx 300 families])
Participant inclusion criteria1. Self-assigned ethnic group using Census 2001 categories as Indian or Pakistani
2. Normal place of residence is in Greater Glasgow & Clyde or Lothian Health board areas
3. Given informed consent
4. Impaired glucose tolerance (IGT) on oral glucose tolerance test (OGTT) at least once
5. An age of 35 or more
6. A waist size of > 90 cm (men) or > 80 cm (women)
7. No confirmed medical history of diabetes (other than gestational diabetes)
Participant exclusion criteria1. The main cook for the potential participant with IGT is unwilling to give consent to cooperate
2. A diagnosis of diabetes made on the OGTT during the screening phase of the study
3. Other disease where adherence to the intervention is contraindicated or improbable e.g. terminal illness or psychological or physical illnesses; alcohol dependency; planned or actual pregnancy; use of prescribed drugs that affect the primary outcome
4. An expectation, reported by participants or the GP, that the person will be emigrating or dying before the conclusion of the trial
5. Failure to make a commitment to stay in the study until, at least, the three year follow-up examination
Recruitment start date01/08/2006
Recruitment end date31/07/2011

Locations

Countries of recruitment

  • Scotland
  • United Kingdom

Study participating centre

Public Health Sciences
Edinburgh
EH8 9AG
United Kingdom

Sponsor information

The Queen’s Medical Research Institute (United Kingdom)
University/education

c/o Ms Marise Brown
The Queens’s Medical Research Institute
47 Little France Crescent
Edinburgh
EH16 4TJ
Scotland
United Kingdom

Phone +44 (0)131 650 3231
Email marise.brown@ed.ac.uk
ROR logo "ROR" https://ror.org/01nrxwf90

Funders

Funder type

Government

MRC National Prevention Research Initiative (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 06/10/2011 Yes No
Results article results 22/02/2013 Yes No
Results article results 01/03/2014 Yes No
Results article results 01/12/2014 Yes No